- Home
- GTIM vs SNSE Comparison
GTIM vs SNSE Comparison
Compare GTIM & SNSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GTIM
- SNSE
- Stock Information
- Founded
- GTIM 1987
- SNSE 2005
- Country
- GTIM United States
- SNSE United States
- Employees
- GTIM N/A
- SNSE N/A
- Industry
- GTIM Restaurants
- SNSE Biotechnology: Pharmaceutical Preparations
- Sector
- GTIM Consumer Discretionary
- SNSE Health Care
- Exchange
- GTIM Nasdaq
- SNSE Nasdaq
- Market Cap
- GTIM 17.1M
- SNSE 14.5M
- IPO Year
- GTIM 1990
- SNSE 2021
- Fundamental
- Price
- GTIM $1.38
- SNSE $8.87
- Analyst Decision
- GTIM
- SNSE Strong Buy
- Analyst Count
- GTIM 0
- SNSE 5
- Target Price
- GTIM N/A
- SNSE $72.50
- AVG Volume (30 Days)
- GTIM 207.1K
- SNSE 77.9K
- Earning Date
- GTIM 12-11-2025
- SNSE 11-07-2025
- Dividend Yield
- GTIM N/A
- SNSE N/A
- EPS Growth
- GTIM 17.03
- SNSE N/A
- EPS
- GTIM 0.12
- SNSE N/A
- Revenue
- GTIM $143,398,000.00
- SNSE N/A
- Revenue This Year
- GTIM N/A
- SNSE N/A
- Revenue Next Year
- GTIM N/A
- SNSE N/A
- P/E Ratio
- GTIM $11.36
- SNSE N/A
- Revenue Growth
- GTIM 1.78
- SNSE N/A
- 52 Week Low
- GTIM $1.24
- SNSE $5.00
- 52 Week High
- GTIM $2.90
- SNSE $18.35
- Technical
- Relative Strength Index (RSI)
- GTIM 38.92
- SNSE 43.42
- Support Level
- GTIM $1.24
- SNSE $8.33
- Resistance Level
- GTIM $2.09
- SNSE $12.40
- Average True Range (ATR)
- GTIM 0.15
- SNSE 1.61
- MACD
- GTIM -0.03
- SNSE -0.39
- Stochastic Oscillator
- GTIM 12.35
- SNSE 5.88
About GTIM Good Times Restaurants Inc.
Good Times Restaurants Inc is engaged in developing, owning, operating, and franchising hamburger-oriented drive-through restaurants. It operates through two segments: Good Times Burgers and Frozen Custard restaurants which operate in the quick-service drive-through dining industry; and Bad Daddy's Burger Bar restaurants which operate in the full-service upscale casual dining industry. The company generates maximum revenue from the Bad Daddy's Burger Bar restaurants segment. Its menu categories include burgers; chicken; frozen custard; slides and drinks.
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).